A Bay Area biotech firm is laying off 75% of its staff following a flopped clinical trial. Allakos, based in San Carlos, ...

Allakos has announced a 75% workforce reduction and the discontinuation of its chronic spontaneous urticaria (CSU ... which dropped by 8.2 points after treatment. By contrast, the placebo group ...

The Phase I trial for AK006 (NCT06072157), which enrolled 34 adults with moderate-to-severe CSU – also known as chronic hives—compared the drug to a placebo. Participants in the AK006 group had a ...

Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company focused on developing innovative therapies for ...

It was the best of biotech times, it was the worst of biotech times: One company soars, another stumbles and a third outlines ...

Feeling a little itchy? Here's how to recognize the most commonly undiagnosed skin irritations, including the one you may ...

They're "not nutritional," a national health program claims.

Executive Editor David Carnoy has been a leading member of CNET's Reviews team since 2000. He covers the gamut of gadgets and is a notable reviewer of mobile accessories and portable audio ...

Commissions do not affect our editors' opinions or evaluations. The best high-yield savings account is Capital One 360 Performance Savings Account™, earning the top rating of 5.0 stars in our study.

Of all the apps available for Apple computers, these are the some of the best you can install on your new iMac or MacBook. Sign up to get the BEST of Tom's Guide direct to your inbox. Here at Tom ...